HealthCap is a specialized venture capital firm investing globally in life sciences, focusing on breakthrough therapeutics for diseases with high unmet medical need. Founded in 1996, the firm has raised over €1.2 billion across nine funds and is headquartered in Stockholm, Sweden with an office in Lausanne, Switzerland.
Deal activity decreased year-over-year (3 deals in the last 12 months vs 5 prior). Average disclosed round size is $60.6M (across 48 rounds with reported amounts).
Portfolio
57
Fund Size
—
Top Stage
Series A
Last 12 Mo
5
Team
Mårten Steen
Managing Partner | MD PhD
Carl-Johan Dalsgaard
Venture Partner | MD PhD
Eugen Steiner
Venture Partner | MD PhD
Georg Vo Beiske
Venture Partner | MSc
Johan Christenson
Partner | MD PhD
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| PPrecirix | Series B | — | Aug 2026 |
 Curify Labs | Series A | $14M | Jul 2026 |
| AAdcendo ApS | Series C | $75M | Apr 2026 |
| Curify Labs | Unknown | — | Feb 2026 |
| HHemab | Series C | $157M | Oct 2025 |
 HelloBetter | Unknown | — | Mar 2025 |
 Gesynta Pharma | Series B | — | Jan 2025 |
| Curify Labs | Unknown | $6.7M | Jan 2025 |
 Intervacc | Unknown | — | Dec 2024 |
 Adcendo | Series B | $135M | Nov 2024 |
| SSynOx Therapeutics | Unknown | $92M | Oct 2024 |
 Kivu Bioscience | Series A | $92M | Oct 2024 |
 Modus Therapeutics | Bridge | — | Jan 2024 |
 Aro Biotherapeutics | Series B | $41.5M | Nov 2023 |
| RRampart Biosciences | Series A | $85M | Oct 2023 |
| HelloBetter | Unknown | — | Sep 2023 |
| AAriceum Therapeutics | Unknown | — | Apr 2023 |
 Hemab Therapeutics | Series B | $135M | Feb 2023 |
| HHemab Therapeutics Holdings | Series B | $135M | Feb 2023 |
| RRampart Bio | Series A | $85M | Jan 2023 |
 Pretzel Therapeutics | Series A | $72.5M | Sep 2022 |
 Ariceum | Series A | — | Jun 2022 |
| AAriceum Therapeutics | Series A | — | Jun 2022 |
 PRECIRIX NV | Series B | — | Mar 2022 |
| AAriceum Therapeutics | Series A | — | Jan 2022 |
Top Co-Investors
Last updated: 8 September 2026